Novo Nordisk A/S (NVO) Stock Chart & Stock Price History $66.53 +1.37 (+2.10%) As of 03:59 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Novo Nordisk A/S Stock Price Performance 5 Day Performance+6.34%1 Month Performance-4.83%3 Month Performance-22.64%6 Month Performance-41.71%Year-To-Date Performance-23.27%1 Year Performance-48.54% Receive NVO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Novo Nordisk A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address NVO Stock Chart for Wednesday, April, 30, 2025 NVO Chart by TradingView Novo Nordisk A/S Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/29/2025$62.61$65.12+4.01%$65.41$64.1610.90 million shs$292.23 billion04/28/2025$62.07$62.61+0.87%$63.25$61.976.28 million shs$280.96 billion04/25/2025$62.59$62.07-0.83%$62.27$60.577.83 million shs$278.54 billion04/24/2025$61.30$62.59+2.11%$62.74$61.847.89 million shs$280.87 billion04/23/2025$59.89$61.30+2.35%$62.43$60.899.07 million shs$275.07 billion04/22/2025$58.37$59.89+2.60%$60.18$58.9211.53 million shs$268.76 billion04/21/2025$57.99$58.37+0.66%$59.30$57.0013.41 million shs$261.94 billion04/18/2025$57.99$57.99$59.06$57.2832.19 million shs$260.23 billion04/17/2025$62.88$57.99-7.78%$59.06$57.2832.19 million shs$260.23 billion04/16/2025$64.46$62.88-2.45%$64.41$62.406.30 million shs$282.18 billion Get the Latest News and Ratings for NVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novo Nordisk A/S and its competitors with MarketBeat's FREE daily newsletter. 04/15/2025$66.00$64.46-2.33%$65.95$63.865.94 million shs$289.27 billion04/14/2025$64.76$66.00+1.92%$66.75$65.338.06 million shs$296.18 billion04/11/2025$61.12$64.76+5.96%$65.00$63.2311.38 million shs$290.59 billion04/10/2025$65.16$61.12-6.21%$63.24$59.329.97 million shs$274.26 billion04/09/2025$61.41$65.16+6.10%$65.30$59.5213.22 million shs$292.41 billion04/09/2025$61.41$65.16+6.10%$65.30$59.5213.22 million shs$292.41 billion04/08/2025$63.52$61.41-3.31%$65.05$60.838.07 million shs$275.60 billion04/08/2025$63.52$61.41-3.31%$65.05$60.838.07 million shs$275.60 billion04/07/2025$62.58$63.52+1.49%$65.28$60.6114.54 million shs$285.03 billion04/04/2025$67.08$62.58-6.71%$65.47$62.3710.85 million shs$280.84 billion04/03/2025$68.20$67.08-1.64%$68.54$67.008.82 million shs$301.04 billion04/02/2025$68.00$68.20+0.29%$68.72$67.327.30 million shs$306.05 billion04/01/2025$69.58$68.00-2.27%$70.00$67.646.21 million shs$305.16 billion03/31/2025$69.36$69.58+0.32%$69.63$66.886.82 million shs$312.24 billion Related Companies Novartis Stock Chart AstraZeneca Stock Chart Sanofi Stock Chart GSK Stock Chart Takeda Pharmaceutical Stock Chart argenx Stock Chart BioNTech Stock Chart Beigene Stock Chart Summit Therapeutics Stock Chart Teva Pharmaceutical Industries Stock Chart Receive NVO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Novo Nordisk A/S and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:NVO) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVO Stock Free NVO Stock Alerts